Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
about
Muscle wasting in animal models of severe illnessExtracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data.Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes.Nitric Oxide does not mediate Atrogin-1/MAFbx upregulation by inflammatory mediators.The regulation of muscle mass by endogenous glucocorticoids.Regulation of ubiquitin-proteasome and autophagy pathways after acute LPS and epoxomicin administration in mice.C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wastingThe NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysisNutritional Assessment in Critically Ill Patients.Curcumin and muscle wasting: a new role for an old drug?Relation between extent of myostatin depletion and muscle growth in mature mice.Preventive effects of kilohertz frequency electrical stimulation on sepsis-induced muscle atrophy.p38 mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 (MK2) signaling in atrophic and hypertrophic denervated mouse skeletal muscleTraditional Chinese medicine: a treasured natural resource of anticancer drug research and development.F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Endotoxin transiently inhibits protein synthesis through Akt and MAPK mediating pathways in C2C12 myotubes.Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential rMAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease.Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases MuRF1 and MAFbx.Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.Short-term feed deprivation rapidly induces the protein degradation pathway in skeletal muscles of young mice.Morphological, molecular and hormonal adaptations to early morning versus afternoon resistance training.Curcumin counteracts loss of force and atrophy of hindlimb unloaded rat soleus by hampering neuronal nitric oxide synthase untethering from sarcolemma.Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.Electrical Stimulation Prevents Preferential Skeletal Muscle Myosin Loss in Steroid-Denervation Rats
P2860
Q27000450-2131304F-39B8-4145-AD15-4A60973E77F1Q30405450-A9F12216-F8E3-484A-BFA6-0D1515CD2BFBQ30433011-D94A2B34-C6B2-4FE8-AE04-92887E8453D6Q30989974-1D2DB9EA-DACE-4FF8-A295-B7199A1C4F2BQ33988273-9099D864-D589-486C-A661-62D973F5185AQ34421809-9EA5EE19-5C82-434C-8BA1-ECFB8EE043EFQ34555764-CEC563C6-A8B6-480E-810D-BDDEB352973FQ34997536-5AC13510-6267-4221-9B95-B9057020E4A3Q35042169-88377B10-82CC-4048-83CC-9356B3E96F3EQ35178582-891F2DE5-7634-4190-94DE-7F5A10EF44C3Q35422257-26B25549-1FBA-4140-ABF1-FE32C3B84FA2Q36517738-B11423AD-6C33-497C-99B7-E73D097916C9Q36924994-AEBD9B60-519A-478E-9800-FB932DE17556Q37332891-AE2803F8-4703-4AF4-BAB6-273ADCE7DA64Q37391771-49449A08-86FA-4119-9953-08920803FD95Q37421345-64F9121D-2BF5-4173-BE48-A70783F36693Q37716475-C06104A5-2D07-4ACB-9EC2-0658BC41D56FQ38215673-15EC802D-5C12-40DA-8A23-C4806163BAF7Q38577674-A02719E1-0D01-40C0-A482-0F8A0B2391C0Q39503456-EAA97444-887B-4143-8C3A-E77CAD026EE9Q42058317-FD611994-1C77-49A1-8127-61CD8DED89AFQ43575761-F9F5C96E-874F-4071-88C7-BEA1F448DAB2Q44321000-B578097E-6CE3-45A1-A221-DBC818564EF9Q46124610-66A95E6C-19A0-4A84-A352-8EB67CB5B603Q46359228-3FFE10E8-1C03-485B-823E-69EA1DA5884FQ46386878-B92A564C-AC9C-4A81-A90D-A06132A242CCQ47240111-D739A691-7498-42CD-A675-D3807250B446Q52649191-278F3BD8-240A-4F41-A043-611E49CF2802Q54448314-F30F22E2-B47B-42CD-944D-078810FD6EEBQ55653938-556ED86F-2B5D-43E7-94F6-885742852BB2Q58789883-58D57B43-6D9F-4338-893B-48955BCC668C
P2860
Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@ast
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@en
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@nl
type
label
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@ast
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@en
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@nl
prefLabel
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@ast
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@en
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@nl
P2860
P356
P1476
Curcumin prevents lipopolysacc ...... gulation and muscle mass loss.
@en
P2093
Bingwen Jin
Yi-Ping Li
P2860
P304
P356
10.1002/JCB.21060
P577
2007-03-01T00:00:00Z